NCT04398732View on ClinicalTrials.gov

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

CompletedOBSERVATIONAL
Enrollment

486

Participants

Timeline

Start Date

July 5, 2020

Primary Completion Date

October 1, 2020

Study Completion Date

October 1, 2020

Conditions
Plaque Psoriasis
Interventions
DRUG

Enbrel

As provided in real world practice

Trial Locations (1)

Unknown

Pfizer, Baghdad

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04398732 - Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients | Biotech Hunter | Biotech Hunter